NYSE - Delayed Quote USD

Alcon Inc. (ALC)

Compare
90.68 -0.67 (-0.73%)
At close: June 14 at 4:00 PM EDT
90.68 +0.01 (+0.01%)
After hours: June 14 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
9,562,000.00
9,455,000.00
8,717,000.00
8,291,000.00
6,833,000.00
--
Cost of Revenue
4,238,000.00
4,208,000.00
3,969,000.00
3,639,000.00
3,893,000.00
--
Gross Profit
5,324,000.00
5,247,000.00
4,748,000.00
4,652,000.00
2,940,000.00
--
Operating Expense
4,185,000.00
4,208,000.00
4,076,000.00
4,072,000.00
3,422,000.00
--
Operating Income
1,139,000.00
1,039,000.00
672,000.00
580,000.00
-482,000.00
--
Net Non Operating Interest Income Expense
-133,000.00
-155,000.00
-130,000.00
-127,000.00
-127,000.00
--
Other Income Expense
--
-52,000.00
-79,000.00
-35,000.00
-26,000.00
--
Pretax Income
954,000.00
832,000.00
463,000.00
418,000.00
-635,000.00
--
Tax Provision
-94,000.00
-142,000.00
128,000.00
42,000.00
-104,000.00
--
Net Income Common Stockholders
1,048,000.00
974,000.00
335,000.00
376,000.00
-531,000.00
--
Diluted NI Available to Com Stockholders
1,048,000.00
974,000.00
335,000.00
376,000.00
-531,000.00
--
Basic EPS
2.13
--
0.68
0.77
-1.09
-1.34
Diluted EPS
2.11
--
0.68
0.76
-1.09
-1.34
Basic Average Shares
493,350.00
--
491,400.00
490,000.00
489,000.00
488,200.00
Diluted Average Shares
496,775.00
--
494,400.00
493,400.00
489,000.00
488,200.00
Total Operating Income as Reported
1,139,000.00
1,039,000.00
672,000.00
580,000.00
-482,000.00
--
Total Expenses
8,423,000.00
8,416,000.00
8,045,000.00
7,711,000.00
7,315,000.00
--
Net Income from Continuing & Discontinued Operation
1,048,000.00
974,000.00
335,000.00
376,000.00
-531,000.00
--
Normalized Income
1,079,200.00
1,021,580.00
392,196.00
407,500.00
-509,264.00
--
Interest Income
--
45,000.00
16,000.00
3,000.00
6,000.00
--
Interest Expense
187,000.00
189,000.00
134,000.00
120,000.00
124,000.00
--
Net Interest Income
-133,000.00
-155,000.00
-130,000.00
-127,000.00
-127,000.00
--
EBIT
1,141,000.00
1,021,000.00
597,000.00
538,000.00
-511,000.00
--
EBITDA
2,356,000.00
2,242,000.00
1,720,000.00
1,757,000.00
1,112,000.00
--
Reconciled Cost of Revenue
4,238,000.00
4,208,000.00
3,969,000.00
3,639,000.00
3,893,000.00
--
Reconciled Depreciation
1,215,000.00
1,221,000.00
1,123,000.00
1,219,000.00
1,623,000.00
--
Net Income from Continuing Operation Net Minority Interest
1,048,000.00
974,000.00
335,000.00
376,000.00
-531,000.00
--
Total Unusual Items Excluding Goodwill
-52,000.00
-52,000.00
-79,000.00
-35,000.00
-26,000.00
--
Total Unusual Items
-52,000.00
-52,000.00
-79,000.00
-35,000.00
-26,000.00
--
Normalized EBITDA
2,408,000.00
2,294,000.00
1,799,000.00
1,792,000.00
1,138,000.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-20,800.00
-4,420.00
-21,804.00
-3,500.00
-4,264.00
--
12/31/2019 - 4/9/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

COO The Cooper Companies, Inc.
93.47
-0.77%
 
BLCO Bausch + Lomb Corporation
15.09
+1.48%
 
HOLX Hologic, Inc.
71.79
-0.49%
 
WST West Pharmaceutical Services, Inc.
333.25
-0.90%
 
STVN Stevanato Group S.p.A.
17.77
-2.90%
 
ANIK Anika Therapeutics, Inc.
26.28
+1.19%
 
MMSI Merit Medical Systems, Inc.
81.80
-1.12%
 
BDX Becton, Dickinson and Company
233.73
+0.76%
 
AZTA Azenta, Inc.
53.91
-1.55%
 
XRAY DENTSPLY SIRONA Inc.
26.11
-2.21%